EUVIMEDEUVIMED entdecken
Crossref

Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit

Elad Asher, Louay Taha, Mohammad Karmi, Akiva Brin, Pierre Sabouret, Mamas A Mamas, Noam Fink, Ari Naimark, Amjad Abu-Salman, Michael Glikson

Thrombosis and Haemostasis · 11.09.2026

DOI: 10.1055/a-2944-1196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 11.09.2026. Verfasst von Elad Asher und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jesselson Integrated Heart Center, Shaare Zedek Medical Center, The Eisenberg R&D Authority, and Faculty of Medicine, Hebrew University of Jerusalem,…. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelet activation and thrombopoiesis are central to acute cardiovascular disease pathophysiology, yet the prognostic role of the immature platelet fraction (IPF) remains incompletely defined in heterogeneous intensive cardiovascular care unit (ICCU) populations. We conducted a single-center, observational study of 6,725 consecutive ICCU admissions with IPF measured. The primary endpoint was in-hospital all-cause mortality using multivariable logistic regression, and discrimination by receiver operating characteristic analysis. Median age was 70 years; 31.8% were women. Increasing IPF quartiles showed a stepwise rise in mortality (2.1 to 3.7%; p-trend = 0.003), acute renal failure (ARF) (2.4 to 5.1%; p < 0.001), malignant arrhythmia (0.9 to 2.2%; p = 0.002), and in-hospital cardiogenic shock (2.7 to 4.7%; p = 0.008); the regression analysis for cardiogenic shock was restricted to incident cases among non-shock admissions (n = 5,778). After multivariable adjustment, each 1 natural-log-unit increment in IPF (∼1.7× raw IPF) remained independently associated with mortality (OR 1.55, 95% CI: 1.10–2.19), ARF (OR 1.75, 1.37–2.25), malignant arrhythmia (OR 2.07, 1.44–2.98), and cardiogenic shock (OR 1.51, 1.16–1.96). Discrimination of IPF alone was modest (AUC 0.57–0.59), but incorporation into multivariable models improved performance (mortality AUC 0.78). Reclassification analysis demonstrated incremental value beyond baseline (categorical net reclassification improvement [NRI] +6.9 to +12.1%; continuous NRI 0.14–0.28). In this large, contemporary ICCU cohort, elevated IPF was independently associated with in-hospital mortality, as well as adverse outcomes. Although not a standalone discriminator, IPF is a readily available, low-cost biomarker that may enhance early mortality risk stratification when integrated with established clinical variables, supporting further evaluation in multimodal and machine learning–based prediction frameworks.

Autor:innen und Institutionen

  • Jesselson Integrated Heart Center, Shaare Zedek Medical Center, The Eisenberg R&D Authority, and Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Shaare Zedek Medical Center, Department of Cardiology, Israel, Jerusalem.
  • ACTION Study Group, Institut de Cardiologie, Sorbonne Université, Hôpital Pitié-Salpêtrière, Cardiology Department, Île-de-France, France, Paris.
  • French National College of Cardiologists, Department of Cardiology, Ile-de-France, France, Paris.
  • Centre for Prognosis Research, Keele University, Keele Cardiovascular Research Group, Staffordshire, United Kingdom of Great Britain and Northern Ireland, Keele.
  • Assuta Medical Centers, Faculty of Medicine, Hebrew University of Jerusalem, Tel Aviv District, Israel, Tel Aviv-Yafo.

Zitieren

APA

Asher, E., Taha, L., Karmi, M., Brin, A., Sabouret, P., Mamas, M. A., Fink, N., Naimark, A., Abu-Salman, A., & Glikson, M. (2026). Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2944-1196

Vancouver

Asher E, Taha L, Karmi M, Brin A, Sabouret P, Mamas MA, et al. Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2944-1196

BibTeX
@article{Asher2026,
  author = {Asher, Elad and Taha, Louay and Karmi, Mohammad and Brin, Akiva and Sabouret, Pierre and Mamas, Mamas A and Fink, Noam and Naimark, Ari and Abu-Salman, Amjad and Glikson, Michael},
  title = {Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1055/a-2944-1196}
}
Kostenlos starten →